GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hansen Medical Inc (NAS:HNSN) » Definitions » Piotroski F-Score

Hansen Medical (Hansen Medical) Piotroski F-Score : 0 (As of May. 25, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Hansen Medical Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Hansen Medical has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for Hansen Medical's Piotroski F-Score or its related term are showing as below:


Hansen Medical Piotroski F-Score Historical Data

The historical data trend for Hansen Medical's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hansen Medical Piotroski F-Score Chart

Hansen Medical Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.00 1.00 4.00 2.00 3.00

Hansen Medical Quarterly Data
Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.00 4.00 3.00 3.00 3.00

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar16) TTM:Last Year (Mar15) TTM:
Net Income was -12.507 + -10.227 + -11.54 + -9.672 = $-43.95 Mil.
Cash Flow from Operations was -11.044 + -11.06 + -7.666 + -7.878 = $-37.65 Mil.
Revenue was 3.092 + 3.183 + 3.999 + 3.042 = $13.32 Mil.
Gross Profit was 0.358 + 0.204 + -0.715 + 0.966 = $0.81 Mil.
Average Total Assets from the begining of this year (Mar15)
to the end of this year (Mar16) was
(77.643 + 65.01 + 54.705 + 45.718 + 34.668) / 5 = $55.5488 Mil.
Total Assets at the begining of this year (Mar15) was $77.64 Mil.
Long-Term Debt & Capital Lease Obligation was $0.00 Mil.
Total Current Assets was $26.03 Mil.
Total Current Liabilities was $42.29 Mil.
Net Income was -12.29 + -15.594 + -11.917 + -11.933 = $-51.73 Mil.

Revenue was 6.887 + 3.877 + 5.032 + 5.794 = $21.59 Mil.
Gross Profit was 1.902 + 0.701 + 0.003 + 1.156 = $3.76 Mil.
Average Total Assets from the begining of last year (Mar14)
to the end of last year (Mar15) was
(61.914 + 53.884 + 63.665 + 53.675 + 77.643) / 5 = $62.1562 Mil.
Total Assets at the begining of last year (Mar14) was $61.91 Mil.
Long-Term Debt & Capital Lease Obligation was $34.23 Mil.
Total Current Assets was $68.73 Mil.
Total Current Liabilities was $26.80 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Hansen Medical's current Net Income (TTM) was -43.95. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Hansen Medical's current Cash Flow from Operations (TTM) was -37.65. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar15)
=-43.946/77.643
=-0.5660008

ROA (Last Year)=Net Income/Total Assets (Mar14)
=-51.734/61.914
=-0.83557838

Hansen Medical's return on assets of this year was -0.5660008. Hansen Medical's return on assets of last year was -0.83557838. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Hansen Medical's current Net Income (TTM) was -43.95. Hansen Medical's current Cash Flow from Operations (TTM) was -37.65. ==> -37.65 > -43.95 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar16)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar15 to Mar16
=0/55.5488
=0

Gearing (Last Year: Mar15)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar14 to Mar15
=34.227/62.1562
=0.55066108

Hansen Medical's gearing of this year was 0. Hansen Medical's gearing of last year was 0.55066108. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar16)=Total Current Assets/Total Current Liabilities
=26.026/42.285
=0.61549013

Current Ratio (Last Year: Mar15)=Total Current Assets/Total Current Liabilities
=68.726/26.799
=2.56449868

Hansen Medical's current ratio of this year was 0.61549013. Hansen Medical's current ratio of last year was 2.56449868. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Hansen Medical's number of shares in issue this year was 18.947. Hansen Medical's number of shares in issue last year was 13.328. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=0.813/13.316
=0.06105437

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=3.762/21.59
=0.17424734

Hansen Medical's gross margin of this year was 0.06105437. Hansen Medical's gross margin of last year was 0.17424734. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar15)
=13.316/77.643
=0.1715029

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar14)
=21.59/61.914
=0.3487095

Hansen Medical's asset turnover of this year was 0.1715029. Hansen Medical's asset turnover of last year was 0.3487095. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+1+1+1+0+0+0+0
=3

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Hansen Medical has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

Hansen Medical  (NAS:HNSN) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Hansen Medical Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Hansen Medical's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Hansen Medical (Hansen Medical) Business Description

Traded in Other Exchanges
N/A
Address
Hansen Medical Inc, formerly known as AutoCath Inc, was incorporated in Delaware in 2002. The Company completed its initial public offering on February 28, 2014. The Company develops, manufactures and sells medical robotics designed for accurate positioning, manipulation and stable control of catheters and catheter-based technologies. Its products include Sensei Robotic Catheter System, Magellan Robotic System, Artisan catheter, Lynx catheter, Magellan Robotic Catheter, and CoHesion 3D Visualization Module. Sensei Robotic Catheter System, or Sensei system, is designed to allow physicians to navigate flexible catheters with solid stability and control in interventional procedures within the atrial heart chambers. This system enables physicians to direct the movements of a robotic catheter like the Company's Artisan Control Catheter and Artisan Extend Control Catheter, or Artisan catheters, and Lynx Robotic Ablation Catheter, or Lynx catheter, to an anatomical location. The Sensei system is comprised of two modules: a physician control console and a patient-side module that can be connected to procedure tables. The control console can be located inside the Electro-Physiology Laboratory, or EP lab, and close to the patient or outside the EP lab in a separate location shielded from radiation. The Company's Magellan Robotic System is a peripheral vascular interventional platform that, used in combination with the Magellan Robotic Catheters, has the potential to provide endovascular specialists with vessel navigation, catheter stability during the manual delivery and placement of therapeutic devices, reduced procedural radiation exposure and fatigue, and precise robotic control of distal catheter tips. Magellan Robotic System is comprised of two modules: a physician control console and a patient-side robotic arm that can be connected to procedure tables. The Artisan catheter is a disposable catheter and guide catheter assembly that consists of a telescoping set of control catheters that are integrated to provide the desired motion of the tip of a diagnostic or therapeutic catheter that is inserted through the center lumen of the Artisan catheter. This is designed to accurately control the movement of a third party catheter chosen by the physician. CoHesion 3D Visualization Module, or CoHesion Module, is a software interface between Sensei system and the St. Jude Medical EnSite System for EP procedures. It is designed to provide physicians with 3D visualization to augment their ability to move a catheter throughout the atria, as well as increase control over placement of the catheter in specific locations. The Company markets, sells and supports its products in the United States through a direct sales force of regional sales employees, supported by clinical account managers who provide training, clinical support and other services to customers. Outside the United States, in the European Union, it uses a combination of a direct sales for
Executives
William R Rohn director PO BOX 676367, RANCHO SANTA FE CA 92067
Christopher P. Lowe director, officer: Interim CFO 2511 N LOOP 1604,, SUITE 204, SAN ANTONIO TX 78258
Oracle Institutional Partners L P 10 percent owner 200 GREENWICH AVENUE, 3RD FLOOR, GREENWICH CT 06830
Oracle Partners Lp 10 percent owner 200 GREENWICH AVE, 3RD FL, GREENWICH CT 06830
Larry N Feinberg 10 percent owner C/O ORACLE PARTNERS L P, 200 GREENWICH AVENUE, GREENWICH CT 06830
Oracle Associates Llc 10 percent owner 200 GREENWICH AVENUE, 3RD FLOOR, GREENWICH CT 06830
Stephen L Newman director 13737 NOEL ROAD, SUITE 100, DALLAS TX 75093
Oracle Ten Fund Master, Lp 10 percent owner C/O ORACLE INVESTMENT MANAGEMENT, INC., 200 GREENWICH AVENUE, GREENWICH CT 06830
Jack W. Schuler Living Trust other: Former 10% Owner 100 NORTH FIELD DRIVE, SUITE 360, LAKE FOREST IL 60045
Family Foundation Schuler other: Former 10% Owner 100 N. FIELD DRIVE, SUITE 360, LAKE FOREST IL 60045
Marjorie L. Bowen director 225 6TH STREET, MANHATTAN BEACH CA 90266
Jack W Schuler director, 10 percent owner 100 N. FIELD DRIVE, SUITE 360, LAKE FOREST IL 60045
Peter J Mariani officer: Chief Financial Officer C/O GUIDANT CORP, 111 MONUMENT CIRCLE #2900, INDIANAPOLIS IN 46204-5129
Bruce Barclay director
Russell C Hirsch director 435 TASSO STREET, SUITE 200, PALO ALTO CA 94301